ASP Isotopes Inc. Reports Material Agreement and Equity Sales
Ticker: ASPI · Form: 8-K · Filed: Nov 14, 2025 · CIK: 1921865
Sentiment: neutral
Topics: material-agreement, debt-obligation, equity-sale
TL;DR
ASP Isotopes inked a material deal, took on debt, and sold stock on Nov 7th.
AI Summary
ASP Isotopes Inc. filed an 8-K on November 14, 2025, reporting on events that occurred on November 7, 2025. The filing indicates the company entered into a material definitive agreement, created a direct financial obligation, and had unregistered sales of equity securities. It also includes financial statements and exhibits.
Why It Matters
This filing signals significant corporate actions by ASP Isotopes Inc., including new financial obligations and equity transactions, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement, a direct financial obligation, and unregistered sales of equity, all of which can introduce financial and operational risks.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- November 7, 2025 (date) — Earliest event reported
- November 14, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 001-41555 (identifier) — SEC File Number
- 87-2618235 (identifier) — IRS Employer Identification No.
FAQ
What was the nature of the material definitive agreement entered into by ASP Isotopes Inc. on November 7, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
What type of direct financial obligation did ASP Isotopes Inc. create?
The filing states the creation of a direct financial obligation, but the specific terms and amount of the obligation are not detailed in this summary.
Were there any unregistered sales of equity securities by ASP Isotopes Inc. on or around November 7, 2025?
Yes, the filing explicitly mentions 'Unregistered Sales of Equity Securities' as an item of information reported.
What is the primary business of ASP Isotopes Inc. according to the filing?
ASP Isotopes Inc. is classified under the Standard Industrial Classification code 2890, which is 'MISCELLANEOUS CHEMICAL PRODUCTS'.
When is ASP Isotopes Inc.'s fiscal year end?
ASP Isotopes Inc.'s fiscal year ends on December 31.
Filing Stats: 2,454 words · 10 min read · ~8 pages · Grade level 15.1 · Accepted 2025-11-14 16:47:28
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
- $64.3 million — r the Securities Act) for approximately $64.3 million of QLE 2025 Notes. The initial closing
- $20 m — ate gross proceeds to QLE of at least US$20 million, excluding proceeds from the issu
- $400,000,000 — and (B) the price obtained by dividing $400,000,000, plus the sum of any monies raised as p
Filing Documents
- aspi_8k.htm (8-K) — 50KB
- aspi_ex101.htm (EX-10.1) — 181KB
- aspi_ex102.htm (EX-10.2) — 115KB
- 0001477932-25-008327.txt ( ) — 541KB
- aspi-20251107.xsd (EX-101.SCH) — 5KB
- aspi-20251107_lab.xml (EX-101.LAB) — 15KB
- aspi-20251107_cal.xml (EX-101.CAL) — 1KB
- aspi-20251107_pre.xml (EX-101.PRE) — 10KB
- aspi-20251107_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. Offering of Convertible Notes of Quantum Leap Energy LLC On November 7, 2025, Quantum Leap Energy LLC ("QLE"), a wholly owned subsidiary of ASP Isotopes Inc. ("ASPI"), entered into a Convertible Note Purchase Agreement (the "Purchase Agreement") with certain institutional and individual investors (collectively, the "Purchasers"), to issue and sell to the Purchasers convertible promissory notes of QLE (the "QLE 2025 Notes") in an offering to accredited investors under Regulation D or Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), or investors who are not a person in the United States or a U.S. Person (within the meaning of Rule 902(k) of Regulation S promulgated under the Securities Act) for approximately $64.3 million of QLE 2025 Notes. The initial closing of the offering is expected to be on or about November 17 or 18, 2025, subject to satisfaction of customary closing conditions, and at such initial closing or in subsequent closings, QLE may issue additional QLE 2025 Notes to investors who are non-U.S. persons in transactions outside of the United States in reliance on Regulation S promulgated under the Securities Act. QLE intends to use the net proceeds from the offering of QLE 2025 Notes to build and develop its laser enrichment production facilities and for other general corporate purposes. Upon the initial closing of the issuance of the QLE 2025 Notes, QLE's outstanding convertible promissory notes originally issued in March 2024 and June 2024 (together, the "2024 Convertible Notes") will automatically convert into additional QLE 2025 Notes pursuant to their terms. Neither QLE nor ASPI will receive any proceeds from the automatic conversion of the 2024 Convertible Notes into QLE 2025 Notes. Canaccord Genuity LLC acted as placement agent in the United States. Ocean Wall Limited is acting as placement agent with respect to certain Purchasers that are non-U.S. persons o
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities. The information set forth in Item 1.01 above under the heading " Offering of Convertible Notes of Quantum Leap Energy LLC " is incorporated herein by reference.
Forward-Looking Statements
Forward-Looking Statements 4
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 10.1 Form of Convertible Note Purchase Agreement (including Form of Convertible Promissory QLE Note), by and among Quantum Leap Energy LLC and the Purchasers party thereto. 10.2 Form of Registration Rights Agreement, by and among Quantum Leap Energy LLC and the Investors party thereto. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 5
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: November 14, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 6